This diagnostic procedure is a rapid immunoassay designed to detect the presence of feline leukemia virus (FeLV) antigen and feline immunodeficiency virus (FIV) antibodies in a cat’s blood, serum, or plasma. The test utilizes a lateral flow format, providing results within minutes. A positive result indicates the cat is likely infected with FeLV or has been exposed to FIV, while a negative result suggests the absence of infection or exposure at the time of testing.
Early detection of these viruses is critical for managing feline health. Knowing a cat’s FeLV and FIV status allows for proactive veterinary care, including monitoring for secondary infections, implementing preventative measures to avoid spreading the viruses to other cats, and making informed decisions regarding long-term care and lifestyle adjustments. This form of testing has become a standard component of feline veterinary care, significantly improving the health and longevity of infected cats.